Health and Safety
All Tai High products are proudly manufactured in New Zealand to the highest quality standards and meet or exceed all legal requirements.
We want you to be safe at all times when using our product, so please read the below rules and information on Tai High.
- Made from a mix of natural and synthetic ingredients including JWH 018 and AM2201. Strictly R18.
- Do not drive or operate heavy machinery within 6 hours of using product.
- Have one toke and wait 10 minutes to feel the effects, gauge the strength before consuming more.
- Do not use to excess, may cause anxiety in sensitive persons.
- Must not be used by pregnant or breastfeeding women. Should not be mixed with drugs or medicines, especially blood pressure lowering medicines. Should not be used by anyone with any heart condition, compromised lung or liver function, or history of mental illness, especially depression, anxiety, panic attacks or schizophrenia, or by anyone who has previously experienced adverse or unusual responses to cannabis.
- Discontinue use immediately in the event of panic attack, persisting paranoia or psychotic symptoms. Frequent or daily use is not recommended, users should be aware that development of dependence on this type of product has rarely been reported, and appropriate limitations on use may be required in some individuals.
- Enjoy Tai High responsibly and in moderation.
Is Tai High Safe?
The Expert Advisory Committee on Drugs (“EACD”) is established under section 5AA of the Misuse of Drugs Act 1975 to advise the Minister of Health on drug classification issues. The EACD:
* conducts reviews of controlled drugs and other narcotic or psychotropic substances
* recommends to the Minister of Health whether and how such substances should be classified
* increases public awareness of its work by (for instance) releasing papers, reports and recommendations.
The EACD is chaired by Dr Ashley Bloomfield, the Ministry of Health’s Chief Advisor on Public Health. Other clinical members of the EACD include:
* Dr Keith Bedford, the Institute of Environmental Science and Research’s General Manager Forensics;
* Associate Professor Tim Maling, Clinical Associate Professor at the University of Otago’s Wellington School of Medicine;
* Dr Geoffrey Robinson, Chief Medical Officer at the Capital and Coast District Health Board; and
* Professor Doug Sellman, Director of the National Addiction Centre at the University of Otago’s Christchurch School of Medicine.
The EACD carried out a Formal Assessment of two synthetic cannabinoids, JWH-018 and JWH-073, on 11 November 2010, and concluded that:
* Synthetic cannabinoids such as JWH-018 and JWH-073 had only entered the market after another substance, CP 47,497, was banned on the basis that it was a chemical analogue to cannabis;
* There was sufficient evidence to suggest that the consumption of JWH-018 and JWH-073 do have the potential to cause harm, despite the lack of robust scientific data on the harm caused by JWH-018 and JWH-073 to date;
* Given the lack of detailed evidence of harm, it was appropriate to restrict, rather than ban, the sale and supply of JWH-018 and JWH-073; and
* JWH-018 and JWH-073 should therefore be made restricted substances, and should not be banned outright.
The Associate Health Minister, Hon Peter Dunne, accepted this recommendation on 30 March 2011, and it is expected that the required legislation will be in place by 2012
The EACD have therefore assessed synthetic cannabinoids as having a lower potential for harm than cannabis, codeine, or Ecstasy. Nevertheless, we think that the Government has made the right decision in moving to stop under-18s from being able to purchase products like Tai High. Tai High is not for under-18s and should never be supplied to under-18s. We are also in favour of controls on the packaging of synthetic cannabinoids and limits on where they can be sold. While the from synthetic cannabinoids are lower than many other substances, safety should always come first.